These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 1309325)

  • 21. Incretin hormones regulate glucose-dependent insulin secretion in RIN 1046-38 cells: mechanisms of action.
    Montrose-Rafizadeh C; Egan JM; Roth J
    Endocrinology; 1994 Aug; 135(2):589-94. PubMed ID: 8033807
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glucagon-like peptide-1(7-37)/(7-36)amide is a new incretin.
    Fehmann HC; Göke R; Göke B
    Mol Cell Endocrinol; 1992 May; 85(1-2):C39-44. PubMed ID: 1382025
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glucagonlike peptide-1(7-36)amide suppresses glucagon secretion and decreases cyclic AMP concentration in cultured In-R1-G9 cells.
    Matsumura T; Itoh H; Watanabe N; Oda Y; Tanaka M; Namba M; Kono N; Matsuyama T; Komatsu R; Matsuzawa Y
    Biochem Biophys Res Commun; 1992 Jul; 186(1):503-8. PubMed ID: 1378730
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Calcium/calmodulin-dependent serine protein kinase is involved in exendin-4-induced insulin secretion in INS-1 cells.
    Zhu ZQ; Wang D; Xiang D; Yuan YX; Wang Y
    Metabolism; 2014 Jan; 63(1):120-6. PubMed ID: 24140090
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is glucagon-like peptide 1 an incretin hormone?
    Nauck MA
    Diabetologia; 1999 Mar; 42(3):373-9. PubMed ID: 10096792
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-diabetic actions of glucagon-like peptide-1 on pancreatic beta-cells.
    Lee YS; Jun HS
    Metabolism; 2014 Jan; 63(1):9-19. PubMed ID: 24140094
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The multifaceted potential of glucagon-like peptide-1 as a therapeutic agent.
    Lam NT; Kieffer TJ
    Minerva Endocrinol; 2002 Jun; 27(2):79-93. PubMed ID: 11961501
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The entero-insular axis: the new incretin candidate glucagon-like peptide-1(7-36)amide (GLP-1(7-36))amide].
    Göke R; Göke B; Richter G; Arnold R
    Z Gastroenterol; 1988 Nov; 26(11):715-9. PubMed ID: 2849249
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Altered glucose regulation of insulin biosynthesis in insulinoma cells: mouse beta TC3 cells secrete insulin-related peptides predominantly via a constitutive pathway.
    Nagamatsu S; Steiner DF
    Endocrinology; 1992 Feb; 130(2):748-54. PubMed ID: 1733723
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulinotropin: glucagon-like peptide I (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas.
    Mojsov S; Weir GC; Habener JF
    J Clin Invest; 1987 Feb; 79(2):616-9. PubMed ID: 3543057
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glucagon-like peptide-1 causes pancreatic duodenal homeobox-1 protein translocation from the cytoplasm to the nucleus of pancreatic beta-cells by a cyclic adenosine monophosphate/protein kinase A-dependent mechanism.
    Wang X; Zhou J; Doyle ME; Egan JM
    Endocrinology; 2001 May; 142(5):1820-7. PubMed ID: 11316746
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exogenous expression of glucagon-like peptide 1 receptor and human insulin in AtT-20 corticotrophs confers cAMP-mediated gene transcription and insulin secretion.
    Sidhu KK; Fowkes RC; Skelly RH; Burrin JM
    J Endocrinol; 2005 Dec; 187(3):419-27. PubMed ID: 16423821
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glucagon-like peptide-1 (7-36 amide): a potent glucagonostatic and insulinotropic hormone.
    Matsuyama T; Komatsu R; Namba M; Watanabe N; Itoh H; Tarui S
    Diabetes Res Clin Pract; 1988 Oct; 5(4):281-4. PubMed ID: 3069410
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glucagon-like peptide-1 regulates the beta cell transcription factor, PDX-1, in insulinoma cells.
    Wang X; Cahill CM; Piñeyro MA; Zhou J; Doyle ME; Egan JM
    Endocrinology; 1999 Oct; 140(10):4904-7. PubMed ID: 10499550
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Somatostatin inhibits glucagon-like peptide-1-induced insulin secretion and proliferation of RINm5F insulinoma cells.
    Stark A; Mentlein R
    Regul Pept; 2002 Oct; 108(2-3):97-102. PubMed ID: 12220732
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glucagon-like peptide-1 and islet lipolysis.
    Sörhede Winzell M; Ahrén B
    Horm Metab Res; 2004; 36(11-12):795-803. PubMed ID: 15655711
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Signal transduction of the GLP-1-receptor cloned from a human insulinoma.
    van Eyll B; Lankat-Buttgereit B; Bode HP; Göke R; Göke B
    FEBS Lett; 1994 Jul; 348(1):7-13. PubMed ID: 7517895
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multisite regulation of insulin secretion by cAMP-increasing agonists: evidence that glucagon-like peptide 1 and glucagon act via distinct receptors.
    Gromada J; Ding WG; Barg S; Renström E; Rorsman P
    Pflugers Arch; 1997 Sep; 434(5):515-24. PubMed ID: 9242714
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glucagon-like peptide-1 structure, function and potential use for NIDDM.
    Gefel D; Barg Y; Zimlichman R
    Isr J Med Sci; 1997 Oct; 33(10):690-5. PubMed ID: 9397146
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the effects of glucagon-like peptide-1-(1-37) and -(7-37) and glucagon on islet hormone release from isolated perfused canine and rat pancreases.
    Kawai K; Suzuki S; Ohashi S; Mukai H; Ohmori H; Murayama Y; Yamashita K
    Endocrinology; 1989 Apr; 124(4):1768-73. PubMed ID: 2564338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.